Sophie Guyonnet, Inserm UMR 1027, Toulouse, France; University of Toulouse III, Toulouse, France; Gérontopôle, Department of Geriatrics, CHU Toulouse, Toulouse, France,
J Frailty Aging. 2021;10(2):110-120. doi: 10.14283/jfa.2020.38.
The Geroscience field focuses on the core biological mechanisms of aging, which are involved in the onset of age-related diseases, as well as declines in intrinsic capacity (IC) (body functions) leading to dependency. A better understanding on how to measure the true age of an individual or biological aging is an essential step that may lead to the definition of putative markers capable of predicting healthy aging.
The main objective of the INStitute for Prevention healthy agIng and medicine Rejuvenative (INSPIRE) Platform initiative is to build a program for Geroscience and healthy aging research going from animal models to humans and the health care system. The specific aim of the INSPIRE human translational cohort (INSPIRE-T cohort) is to gather clinical, digital and imaging data, and perform relevant and extensive biobanking to allow basic and translational research on humans.
The INSPIRE-T cohort consists in a population study comprising 1000 individuals in Toulouse and surrounding areas (France) of different ages (20 years or over - no upper limit for age) and functional capacity levels (from robustness to frailty, and even dependency) with follow-up over 10 years. Diversified data are collected annually in research facilities or at home according to standardized procedures. Between two annual visits, IC domains are monitored every 4-month by using the ICOPE Monitor app developed in collaboration with WHO. Once IC decline is confirmed, participants will have a clinical assessment and blood sampling to investigate markers of aging at the time IC declines are detected. Biospecimens include blood, urine, saliva, and dental plaque that are collected from all subjects at baseline and then, annually. Nasopharyngeal swabs and cutaneous surface samples are collected in a large subgroup of subjects every two years. Feces, hair bulb and skin biopsy are collected optionally at the baseline visit and will be performed again during the longitudinal follow up.
Recruitment started on October 2019 and is expected to last for two years. Bio-resources collected and explored in the INSPIRE-T cohort will be available for academic and industry partners aiming to identify robust (set of) markers of aging, age-related diseases and IC evolution that could be pharmacologically or non-pharmacologically targetable. The INSPIRE-T will also aim to develop an integrative approach to explore the use of innovative technologies and a new, function and person-centered health care pathway that will promote a healthy aging.
衰老科学领域专注于与年龄相关疾病发病和内在能力(IC)(身体功能)下降导致依赖相关的核心生物学机制。更好地了解如何衡量个体的真实年龄或生物衰老,是一个重要的步骤,可能会定义能够预测健康衰老的假定标志物。
预防健康衰老和医学再生研究所(INSPIRE)平台计划的主要目标是建立一个衰老科学和健康衰老研究计划,从动物模型到人类和医疗保健系统。INSPIRE 人类转化队列(INSPIRE-T 队列)的具体目标是收集临床、数字和影像学数据,并进行相关和广泛的生物样本库建设,以便对人类进行基础和转化研究。
INSPIRE-T 队列由 1000 名年龄在 20 岁及以上(年龄无上限)、功能能力水平不同(从健壮到虚弱,甚至依赖)的图卢兹及其周边地区(法国)的个体组成,随访时间为 10 年。根据标准化程序,在研究设施或家中每年收集多样化的数据。两次年度访问之间,每 4 个月使用与世界卫生组织合作开发的 ICOPE Monitor 应用程序监测 IC 领域。一旦确认 IC 下降,参与者将进行临床评估和血液采样,以在 IC 下降时调查衰老标志物。生物样本包括血液、尿液、唾液和牙菌斑,所有受试者在基线时收集,然后每年收集一次。每隔两年,从大量亚组受试者中收集鼻咽拭子和皮肤表面样本。粪便、头发球和皮肤活检在基线就诊时可选,在纵向随访期间将再次进行。
招募工作于 2019 年 10 月开始,预计将持续两年。INSPIRE-T 队列中收集和探索的生物资源将提供给旨在识别衰老、与年龄相关疾病和 IC 演变的稳健(一组)标志物的学术和行业合作伙伴,这些标志物可能具有药理学或非药理学靶向性。INSPIRE-T 还将旨在开发一种综合方法,探索创新技术的使用和一种新的、以功能和人为中心的医疗保健途径,以促进健康衰老。